Evidence map›Paper›PMID 30176942›Full record

ArticleMicrobial cell factories2018

Genome alterations associated with improved transformation efficiency in Lactobacillus reuteri.

Laura Ortiz-Velez, Javiera Ortiz-Villalobos, Abby Schulman, Jee-Hwan Oh, Jan-Peter van Pijkeren, Robert A Britton

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Revised complete genome sequences ofMicrobiology spectrum · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Recent progress on n-butanol production by lactic acid bacteria.World journal of microbiology & biotechnology · 2021
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Laura Ortiz-VelezDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.
Javiera Ortiz-VillalobosComparative Medicine and Integrative Biology, Michigan State University, East Lansing, MI, USA.
Abby SchulmanDepartment of Cognitive Sciences, Rice University, Houston, TX, USA.
Jee-Hwan OhDepartment of Food Science, University of Wisconsin-Madison, Madison, WI, USA.
Jan-Peter van PijkerenDepartment of Food Science, University of Wisconsin-Madison, Madison, WI, USA.
Robert A BrittonDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA. Robert.Britton@bcm.edu.ORCID http://orcid.org/0000-0001-8983-9539
Baylor College of Medicine · USUniversity of Wisconsin–Madison · USMichigan State University · USRice University · US

Funding

TUMOR VACCINES AND BONE MARROW TRANSPLANTATIONP01CA039542 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PAVAN REDDY · 1985 to 2026
$47.9M
National Cancer Institute P01 CA039542-28A1NCI NIH HHS P01 CA039542
6 · The paper itself

Abstract

backgroundLactic acid bacteria (LAB) are one of the microorganisms of choice for the development of protein delivery systems for therapeutic purposes. Although there are numerous tools to facilitate genome engineering of lactobacilli; transformation efficiency still limits the ability to engineer their genomes. While genetically manipulating Lactobacillus reuteri ATCC PTA 6475 (LR 6475), we noticed that after an initial transformation, several LR 6475 strains significantly improved their ability to take up plasmid DNA via electroporation. Our goal was to understand the molecular basis for how these strains acquired the ability to increase transformation efficiency.

resultsStrains generated after transformation of plasmids pJP067 and pJP042 increased their ability to transform plasmid DNA about one million fold for pJP067, 100-fold for pSIP411 and tenfold for pNZ8048. Upon sequencing of the whole genome from these strains, we identified several genomic mutations and rearrangements, with all strains containing mutations in the transformation related gene A (trgA). To evaluate the role of trgA in transformation of DNA, we generated a trgA null that improved the transformation efficiency of LR 6475 to transform pSIP411 and pJP067 by at least 100-fold, demonstrating that trgA significantly impairs the ability of LR 6475 to take-up plasmid DNA. We also identified genomic rearrangements located in and around two prophages inserted in the LR 6475 genome that included deletions, insertions and an inversion of 336 Kb. A second group of rearrangements was observed in a Type I restriction modification system, in which the specificity subunits underwent several rearrangements in the target recognition domain. Despite the magnitude of these rearrangements in the prophage genomes and restriction modification systems, none of these genomic changes impacted transformation efficiency to the level induced by trgA.

conclusionsOur findings demonstrate how genetic manipulation of LR 6475 with plasmid DNA leads to genomic changes that improve their ability to transform plasmid DNA; highlighting trgA as the primary driver of this phenotype. Additionally, this study also underlines the importance of characterizing genetic changes that take place after genome engineering of strains for therapeutic purposes.

Indexed as

Genetic EngineeringGenomicsLimosilactobacillus reuteriGenome engineeringLactobacillus reuteri 6475Mobile genetic elementsProphagepSIP411Transformation efficiency

Identifiers

PMID30176942
PMCPMC6122466
OpenAlexW2889526024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.